Delayed Surgery in Bowel Obstruction: A Hidden Driver of Mortality and Recurrence in France

Highlights

• Early mortality increases progressively with surgical delay, rising from 3.6% when operated within 0-1 days to 7.1% after ≥9 days of waiting.
• Non-operative management is associated with a 2.7-fold higher long-term recurrence rate compared to surgical intervention (23.5% vs 8.8%).
• Laparoscopic surgery provides additional protection against recurrence, reducing the subdistribution hazard ratio to 0.72.
• Bowel resection rates climb alongside surgical delays, emphasizing the consequences of postponement.

Background

Adhesive small bowel obstruction (aSBO) represents one of the most frequent complications following abdominal surgery, accounting for substantial healthcare burden worldwide. The clinical challenge lies in determining the optimal management strategy: whether to pursue non-operative management (NOM) with nasogastric decompression and close observation, or to proceed with surgical intervention.

Current clinical guidelines generally recommend initial non-operative management for uncomplicated aSBO, with the rationale that many episodes will resolve spontaneously without surgery. However, this conservative approach is not without consequences. Delayed surgery—particularly when intestinal viability becomes compromised—carries significant risks that have been difficult to quantify at the population level.

The tension between these two approaches has created an ongoing debate in surgical practice: how long is it safe to observe before committing to operative intervention? Furthermore, the long-term implications of each strategy, particularly regarding recurrence, remain incompletely understood. Population-based studies capable of addressing both immediate risks and long-term outcomes simultaneously have been notably absent from the literature.

Study Design

The research team, led by Chierici and colleagues, addressed these critical knowledge gaps through a nationwide retrospective observational cohort study utilizing the French National Health Data System (SNDS). The study period encompassed nine years, from 2015 to 2024, providing substantial power to detect meaningful differences in outcomes.

The study population included all adults admitted with a primary diagnosis of adhesive small bowel obstruction, representing a comprehensive cross-section of French patients presenting with this condition. The main exposure variable was the management strategy at index admission, categorized as either non-operative management or surgical intervention.

For surgically treated patients, the researchers further categorized surgical timing by days from admission to operation, allowing for detailed analysis of the relationship between delay and outcomes. The primary outcome was early mortality, defined as death within 30 days of admission, analyzed according to surgical delay. Secondary outcomes encompassed bowel resection rates, long-term recurrence of obstruction, and mortality during recurrent admissions.

This study design leverages the strengths of administrative data—large sample size, complete follow-up, and nationwide representation—while acknowledging the inherent limitations of retrospective observational research.

Key Findings

Early Mortality and Surgical Delay

The analysis included 71,573 surgically treated episodes, providing robust data on the relationship between timing of operation and early mortality. The findings demonstrated a clear and concerning gradient: early mortality increased progressively with longer surgical delays. Patients who underwent surgery within the first 0-1 days of admission experienced an early mortality rate of 3.6%. This figure rose steadily with increasing delay, reaching 7.1% among patients who waited nine or more days for surgery—effectively doubling the risk of death within the first month.

This relationship between delay and mortality remained robust after adjustment for potential confounders, suggesting that surgical postponement independently contributes to early death in aSBO patients. The biological plausibility of this finding centers on the progressive ischemic damage that occurs when obstructed bowel segments are deprived of adequate blood supply. As time passes, the risk of transmural necrosis, perforation, and subsequent peritonitis increases substantially.

Bowel Resection Rates

Consistent with the mortality findings, bowel resection rates demonstrated a parallel increase with surgical delay. Among patients operated within 0-1 days, 18.0% required bowel resection. This proportion increased to 24.5% when surgery was delayed for nine or more days. The difference of 6.5 percentage points represents a clinically meaningful increase in morbidity, as bowel resection carries risks of anastomotic leak, short bowel syndrome, and prolonged recovery.

These data suggest that delayed intervention not only threatens survival but also leads to more extensive surgery with greater anatomical and functional consequences for patients.

Long-Term Recurrence Patterns

Perhaps the most striking finding concerned long-term recurrence. During extended follow-up, recurrence of adhesive small bowel obstruction occurred in 23.5% of patients initially managed non-operatively, compared with only 8.8% of those who underwent surgical management. This difference translated to a subdistribution hazard ratio (sHR) of 0.30 (95% CI, 0.29-0.32), indicating that surgical management reduced the hazard of recurrence by approximately 70% compared to non-operative approaches.

This finding challenges the conventional assumption that avoiding surgery automatically leads to better long-term outcomes. While NOM successfully resolves the immediate episode in many cases, it appears to leave patients at substantially elevated risk for recurrent obstruction, potentially necessitating future emergency surgery under less favorable conditions.

Advantages of Laparoscopic Approach

Among surgical patients, the choice of surgical approach proved significant. Laparoscopic surgery was associated with a further reduction in recurrence risk, yielding a subdistribution hazard ratio of 0.72 (95% CI, 0.63-0.81) compared to open surgery. This 28% reduction in recurrence hazard suggests that minimally invasive techniques offer advantages beyond simply reducing short-term wound complications— they may fundamentally alter the natural history of adhesive disease by causing less peritoneal trauma and inflammation.

Mortality During Recurrent Admissions

The study also examined outcomes when patients returned with recurrent obstruction. Mortality during recurrent admissions was notably higher among patients who ultimately required surgery, reflecting the more severe underlying pathology in this population. However, the increased mortality associated with delayed primary surgery raises the question of whether earlier operative intervention might have prevented some of these recurrent episodes and their associated risks.

Expert Commentary

The findings from Chierici and colleagues represent a significant contribution to the management of adhesive small bowel obstruction, providing population-level evidence that has been lacking in this field. The clear demonstration that surgical delay independently predicts both mortality and need for bowel resection reinforces the importance of vigilant assessment and willingness to proceed promptly to the operating room when indicated.

The striking difference in long-term recurrence between NOM and surgical management deserves particular attention. While guidelines appropriately emphasize avoiding unnecessary surgery, these data suggest that the calculus should include not just immediate surgical risks but also the substantial probability of recurrence with its attendant morbidity and mortality. A strategy of prolonged observation that ultimately fails and requires emergency surgery at a later time point—often under worse clinical conditions—may prove more harmful than timely elective operation.

Several limitations warrant consideration. The retrospective, observational design precludes causal inference, and residual confounding may explain some observed associations. The study relies on administrative coding, which may imperfectly capture clinical nuance such as signs of bowel compromise or specific indications for operative intervention. Additionally, the French healthcare context may limit direct generalization to other systems with different practice patterns or patient populations.

Despite these limitations, the scale of the study—encompassing over 71,000 surgical episodes across a nationwide population—provides confidence in the robustness of the primary findings. The temporal gradient between delay and mortality is particularly compelling, as it demonstrates a dose-response relationship that strengthens the argument for causation.

Conclusion

This nationwide French study provides compelling evidence that surgical delay in adhesive small bowel obstruction carries significant short- and long-term consequences. The doubling of early mortality when surgery is delayed beyond nine days, combined with the 2.7-fold increase in long-term recurrence with non-operative management, suggests that clinicians should maintain a low threshold for operative intervention. The additional benefit of laparoscopic surgery in reducing recurrence further supports the adoption of minimally invasive techniques when technically feasible.

For practicing surgeons and emergency physicians, these findings argue for closer monitoring of patients undergoing non-operative management and earlier escalation to surgery when clinical progress is not satisfactory. Future research should focus on identifying specific clinical parameters that predict failure of non-operative management, enabling more personalized decision-making. Until such markers are validated, the pendulum should perhaps swing toward earlier intervention rather than prolonged observation.

References

1. Chierici A, Lareyre F, Backouche A, Massalou D, Balelli I, Delingette H, Raffort J. Managing Adhesive Small Bowel Obstruction: Immediate Risks and Long-Term Burden in France. Annals of Surgery. 2026-03-27. PMID: 41888086.